drugset
Drugs / DNG64-CAR-V
re-read 3 minutes ago

DNG64-CAR-V

also known as DNG64 Chimeric Amphotroopic RNA Vector Encoding a Cyclin G1 Inhibitor

targets CCNG1 via inhibition

Developed for
breast carcinoma · chondrosarcoma · chordoma · glioblastoma · malignant pancreatic neoplasm · malignant peripheral nerve sheath tumor · osteosarcoma
Investigated by
Aveni Foundation

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT04091295 — breast carcinoma, chondrosarcoma, chordoma, glioblastoma +3 Aveni Foundation Available No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DNG64-CAR-V ClinicalTrials.gov intervention name — accepted as the source's own label NCT04091295 ↗
Known as DNG64 Chimeric Amphotroopic RNA Vector Encoding a Cyclin G1 Inhibitor “DNG64 Chimeric Amphotroopic RNA Vector Encoding a Cyclin G1 Inhibitor” NCT04091295 ↗
Action Inhibit “encoding a CCNG1 inhibitor gene” NCT04091295 ↗
Route Intravenous “intravenously” NCT04091295 ↗
Target CCNG1 “encoding a CCNG1 inhibitor gene” NCT04091295 ↗